Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Trident Lifeline Ltd Performance

Today's Low
154.00
arrowIcon
Today's High
160.00
52 Wk Low
128.25
arrowIcon
52 Wk High
239.70


Open

160

Traded Value (Cr)

9.24 L

Prev. Close

159.6

VWAP

158.65

Volume

6,000

Face Value

10

Trident Lifeline Ltd Fundamentals

Market Cap
₹ 183 Cr
P/E Ratio (TTM)
28.91
P/B Ratio
3.54
Debt to Equity
0.35
ROE
11.99 %
EPS (TTM)
5.52
Dividend Yield
0.00%
Book Value
45.14

Click here to know more about Fundamentals

Trident Lifeline Ltd Financials

Trident Lifeline Ltd Financials

Trident Lifeline Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 67.48 % 70.04 % 70.04 % 70.04 %
Retail 16.39 % 14.43 % 14.82 % 14.30 %
Others 10.10 % 10.88 % 10.50 % 11.30 %
FII 6.02 % 4.64 % 4.64 % 4.36 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

67.48%

Retail

16.39%

Others

10.10%

FII

6.02%

Mutual Funds

0.00%

Promoters

70.04%

Retail

14.43%

Others

10.88%

FII

4.64%

Mutual Funds

0.00%

Promoters

70.04%

Retail

14.82%

Others

10.50%

FII

4.64%

Mutual Funds

0.00%

Promoters

70.04%

Retail

14.30%

Others

11.30%

FII

4.36%

Mutual Funds

0.00%

Resistance and Support

₹164.00

PIVOT

resistance-arrow
Resistance
First Resistance₹175.000
Second Resistance₹182.000
Third Resistance₹193.000
support-arrow
Support
First Resistance₹157.000
Second Resistance₹146.000
Third Resistance₹139.000
RSI45.757
MACD-1.347
ADX15.277
CCI-109.473

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day3,6005,40090.00
Week13,08012,48094.42
1 Month6,5675,83388.60
6 Months000.00

About Trident Lifeline Ltd

Trident Lifeline Limited was originally incorporated as Private Limited Company under the name 'Trident Lifeline Private Limited' on January 09, 2014. Subsequently, Company converted into a Public Limited pursuant to Shareholders' Resolution on June 02, 2022 and name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022. The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It operate in India as well as African, Latin American and East Indian Countries. Presently, it has presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venezuela. Presently, Company operates with one contract manufacturer, who maintained relationship with the regular supplier, having FDA and WHO approved plant to supply pharma formulations. These units manufacture tablets, capsules, dry powder, syrup under their own brands. Pharma business operations are supported by various contract manufacturers having facilities which are approved by FDA/WHO and other relevant authorities. The Company typically work on contract manufacturing basis or at times purchase order basis, depending upon customer's requirement, with manufacturer of pharma products. The Company deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. The product portfolio comprises of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflammatory drug (NSAIDS). The Company had Certified its Quality Management System Under the Certificate ISO 9001: 2015 in FY 2021. Besides, product portfolio consists of 832 products, which operated under different brand names across the globe as on May 31, 2022. As on May 31, 2022, the Company has 267 products registered in total 8 countries, of which total 565 products are under process of registration in 11 countries.

Managing Director

Shravan Harikrishna Patel

Founded

2014

NSE Symbol

Trident Lifeline Ltd Management

NameDesignation
Hardik J DesaiChairman & Exec. Director
Mayurkumar Mansukhbhai GajeraWhole Time Director & CFO
Shravan Harikrishna PatelManaging Director
Maniya H DesaiNon Executive Director
Aena SuranaIndependent Director
Mishal Shailesh PatelIndependent Director
Jiteshkumar Ramchandra VarkalCompany Sec. & Compli. Officer

Trident Lifeline Ltd News

Trident Lifeline revises board meeting date
To 27 April 2024
Trident Lifeline to table results
On 22 April 2024
Trident Lifeline to hold board meeting
On 13 March 2024
Trident Lifeline announces incorporation of TLL Parenterals
Board of Trident Lifeline approves acquisition of majority stake in a new pharma entity
At meeting held on 11 December 2023
Trident Lifeline to discuss results
On 4 November 2023
Trident Lifeline to conduct AGM
On 21 September 2023
Trident Lifeline consolidated net profit rises 100.00% in the June 2023 quarter
Sales rise 44.72% to Rs 8.64 crore
Trident Lifeline to discuss results
On 15 July 2023
Trident Lifeline consolidated net profit declines 28.52% in the March 2023 quarter
Sales decline 5.47% to Rs 8.46 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,304 Cr
₹ 1,493.35
(-1.85 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,358.80
(-1.88 %)
33.36
DIVISLAB₹ 1,00,599 Cr
₹ 3,789.50
(-3.55 %)
73.75
DRREDDY₹ 98,073 Cr
₹ 5,879.05
(-2.93 %)
22.59
ZYDUSLIFE₹ 97,383 Cr
₹ 967.80
(-3.77 %)
36.23

Trident Lifeline Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Trident Lifeline Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Trident Lifeline Ltd's share price is ₹154.00 as of May 9, 2024

Trident Lifeline Ltd's P/E ratio is 28.91 times as of May 9, 2024.

Trident Lifeline Ltd's most recent financial reports indicate a price-to-book ratio of 3.54, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Trident Lifeline Ltd's market is 184 Cr as on May 9, 2024.

The current financial records of Trident Lifeline Ltd show a 11.99% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Trident Lifeline Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Trident Lifeline Ltd's 52-week high and low as of May 9, 2024 are ₹160 and ₹154 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Trident Lifeline Ltd stands at 67.48%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 4.64% to 6.02%.